The transcription factor c-Myc is exploited to increase glutamine input by increasing the expression of glutamine transporters including system N transporter 2 (SN2) and alanine-serine-cysteine transporter 2 (ASCT2) in cancer cells (131). Here, SLC1A5 is linked to cancer.